{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:33:16Z","timestamp":1794695596405,"version":"4.9.1"},"reference-count":23,"publisher":"BMJ","issue":"21","funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2018,4,23]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study evaluates the 5-year clinical outcomes of transcatheter mitral valve (MV) repair with the MitraClip device in patients at high risk for MV surgery treated in the Endovascular Valve Edge-to-Edge Repair (EVEREST) II High Risk Study (HRS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with mitral regurgitation (MR) 3+ or 4+ and predicted surgical mortality risk \u226512%\u2009or surgeon assessment based on prespecified high-risk factors were enrolled. Patients prospectively consented to 5 years of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 5 years, clinical follow-up was achieved in 90% of 78 enrolled patients. The rate of postprocedural adverse events declined from 30 days to 1\u2009year follow-up and was stable thereafter through 5 years. Two patients (2.6%) developed mitral stenosis (MS). Two patients underwent MV surgery, including one due to MS. A total of 42 deaths were reported through 5 years. Effectiveness measures at 5 years showed reductions in MR severity to \u22642+ in 75% of patients (p=0.0107), left ventricular (LV) end-diastolic volume (\u221238.2\u2009mL; 95%\u2009CI \u221255.0 to \u201321.4; p&lt;0.0001) and LV end-systolic volume (\u221214.6\u2009mL; 95%\u2009CI \u221227.7 to \u22121.5; p=0.0303) compared with baseline. The New York Heart Association (NYHA) functional class improved from baseline to 5 years (p&lt;0.005), and septal-lateral annular dimensions remained stable with no indication of mitral annular dilation through 5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The EVEREST II HRS demonstrated long-term safety and efficacy of MitraClip in high-surgical-risk patients through 5 years. The observed mortality was most likely a consequence of the advanced age and comorbidity profile of the enrolled patients, while improvements in NYHA class in surviving patients were durable through long-term follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT01940120\" ext-link-type=\"clintrialgov\">NCT01940120<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2017-312605","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T14:25:49Z","timestamp":1533392749000},"page":"1622-1628","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients"],"prefix":"10.1136","volume":"105","clinical-trial-number":[{"clinical-trial-number":"nct01940120","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01626079","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01940120","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Saibal","family":"Kar","sequence":"first","affiliation":[{"name":"Cedars-Sinai Medical Center, Heart Institute, Los Angeles, California, USA"},{"name":"Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Feldman","sequence":"additional","affiliation":[{"name":"Northshore University Health System, Evanston, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Qasim","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Trento","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Heart Institute, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kapadia","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Scott","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kipperman","sequence":"additional","affiliation":[{"name":"Oklahoma Heart Hospital, Oklahoma City, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Smalling","sequence":"additional","affiliation":[{"name":"Memorial Hermann Heart and Vascular Institute\/UT Health, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvir","family":"Bajwa","sequence":"additional","affiliation":[{"name":"Aurora Cardiovascular Services, Aurora Sinai\/Aurora St Luke\u2019s Medical Centers, Milwaukee, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard C","family":"Hermann","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Hermiller","sequence":"additional","affiliation":[{"name":"St Vincent Medical Group, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Lasala","sequence":"additional","affiliation":[{"name":"Washington University, St Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Reisman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Washington Medical Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Glower","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Harvard Clinical Research Institute, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Whitlow","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,8,4]]},"reference":[{"key":"2026052804451098000_105.21.1622.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.08.004"},{"key":"2026052804451098000_105.21.1622.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.067"},{"key":"2026052804451098000_105.21.1622.3","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio1068"},{"key":"2026052804451098000_105.21.1622.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0894-7317(03)00335-3"},{"key":"2026052804451098000_105.21.1622.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2007.02.003"},{"key":"2026052804451098000_105.21.1622.6","first-page":"91","article-title":"MitraClip implantation for high risk patients with severe mitral regurgitation: the Sheba experience","volume":"16","author":"Koifman","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"2026052804451098000_105.21.1622.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2011.09.033"},{"key":"2026052804451098000_105.21.1622.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009355"},{"key":"2026052804451098000_105.21.1622.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr029"},{"key":"2026052804451098000_105.21.1622.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.061"},{"key":"2026052804451098000_105.21.1622.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.021"},{"key":"2026052804451098000_105.21.1622.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.12.062"},{"key":"2026052804451098000_105.21.1622.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.06.1166"},{"key":"2026052804451098000_105.21.1622.14","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300705"},{"key":"2026052804451098000_105.21.1622.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.07.047"},{"key":"2026052804451098000_105.21.1622.16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq050"},{"key":"2026052804451098000_105.21.1622.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq051"},{"key":"2026052804451098000_105.21.1622.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft021"},{"key":"2026052804451098000_105.21.1622.19","first-page":"467","article-title":"Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair","volume":"87","author":"Triantafyllis","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026052804451098000_105.21.1622.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512913"},{"key":"2026052804451098000_105.21.1622.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.077"},{"key":"2026052804451098000_105.21.1622.22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1615\/JLongTermEffMedImplants.2015011729","article-title":"Mechanics of mitral valve edge-to-edge-repair and MitraClip procedure","volume":"25","author":"Bhattacharya","year":"2015","journal-title":"J Long Term Eff Med Implants"},{"key":"2026052804451098000_105.21.1622.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.10.018"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-312605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:10:53Z","timestamp":1780319453000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-312605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,4]]},"references-count":23,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2019,10,10]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/heartjnl-2017-312605"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-312605","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/heartjnl-2017-312605.supp1","asserted-by":"subject"}]},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,4]]}}}